Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Alibaba Health, indicating a reduction of 2.5 million shares on February 13, while there was a net increase of 28.064 million shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have reduced their holdings on 8 occasions, resulting in a total net reduction of 62.917 million shares [1] - As of now, southbound funds hold 1.973 billion shares of Alibaba Health, which represents 12.19% of the company's total issued ordinary shares [1] Group 2 - Alibaba Health Information Technology Co., Ltd. is a holding company that provides industrial internet solutions for the medical and pharmaceutical industry, serving as Alibaba Group's flagship platform in the health sector [1] - The company primarily engages in the sales of pharmaceutical health products, operates an e-commerce platform for pharmaceuticals, and offers consumer healthcare services, leveraging technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

Group 1 - The core viewpoint of the article highlights that southbound funds have increased their holdings in Ping An Good Doctor (01833.HK) by 112,100 shares on February 13, with a total net increase of 8.6263 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings on 12 occasions, resulting in a cumulative net increase of 3.3276 million shares [1] - As of now, southbound funds hold 485 million shares of Ping An Good Doctor, accounting for 22.42% of the company's total issued ordinary shares [1] Group 2 - Ping An Health Medical Technology Co., Ltd. operates in the healthcare sector, providing medical and health services through mobile platforms and offline resources [1] - The company conducts its business through two segments: the medical services segment, which includes online consultations, referrals, appointment scheduling, hospitalization arrangements, disease diagnosis, and related sales of drugs and medical devices [1] - The health services segment offers a variety of standardized health service packages that integrate services from medical health institutions, addressing user health needs across multiple categories such as physical examinations, elderly care, dental services, anti-aging, and general health [1]

证券之星消息，2月13日互联网医疗板块较上一交易日下跌1.08%，东方国信领跌。当日上证指数报收 于4082.07，下跌1.26%。深证成指报收于14100.19，下跌1.28%。互联网医疗板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 从资金流向上来看，当日互联网医疗板块主力资金净流出17.34亿元，游资资金净流入6.91亿元，散户资 金净流入10.43亿元。互联网医疗板块个股资金流向见下表： ...

Core Insights - Southbound funds increased their holdings in Alibaba Health (00241.HK) by 7.354 million shares on February 12 [1] - Over the past 5 trading days, there have been 5 days of net increases in holdings, totaling 34.802 million shares [1] - In the last 20 trading days, there were 13 days of net increases, amounting to 133 million shares [1] - Currently, southbound funds hold 1.976 billion shares of Alibaba Health, representing 12.2% of the company's total issued ordinary shares [1] Company Overview - Alibaba Health Information Technology Co., Ltd. is an investment holding company providing industrial internet solutions for the medical and pharmaceutical industry [1] - The company primarily engages in the sales of pharmaceutical health products, operates a pharmaceutical e-commerce platform, and offers consumer healthcare services [1] - It leverages technologies such as cloud computing and big data to develop traceability, digital healthcare, and internet medical services [1]

来源：滚动播报 （来源：经济参考报） 日前，以线上中医诊疗平台甘草医生为核心的杭州甘之草科技股份有限公司（简称"甘草医生"）向港交 所递交上市申请，中信建投国际和申万宏源香港担任联席保荐人。 业绩方面，2023年、2024年和2025年前三季度，甘草医生营业收入分别为6亿元、6.9亿元和5.5亿元；同 期净利润在2024年达到0.1亿元后，2025年前三季度由盈转亏。对此，甘草医生在招股书中坦言，经营 业绩直接受到销售成本的影响，采购价格的波动、供应链中断及中医药材供应的季节性变化可能会让公 司的单位成本出现波动。 平台对此解释说，其主要面向复诊患者。患者在线下初诊关注医师的平台账号后，可通过线上图文问诊 反馈病情，医师在线开出药方并选择药房。但记者实测发现，问诊过程中，即便不添加实体医疗机构病 历或检查单，也能够正常向平台上的医师问诊抓药，这意味着平台无法确认患者是否为首诊。在向平台 内的一位医师咨询毛囊炎疾病后，该医师仅向记者发送了5句话，便开出一份价格283元、内含6剂的药 方。 记者在进一步测试面向注册医师"甘草医生医生端"App的过程中发现，其对于业务的监管措施和合规成 色同样存疑。记者在"甘草医生 ...

Core Viewpoint - Southbound funds have significantly increased their holdings in Ping An Good Doctor (01833.HK), indicating growing investor confidence in the company [1] Group 1: Southbound Fund Activity - On February 12, southbound funds increased their holdings by 3.9798 million shares of Ping An Good Doctor [1] - Over the past five trading days, there have been five days of net increases, totaling 9.0687 million shares [1] - In the last 20 trading days, there were 11 days of net increases, amounting to 2.2241 million shares [1] - Currently, southbound funds hold 485 million shares of Ping An Good Doctor, representing 22.42% of the company's total issued ordinary shares [1] Group 2: Company Overview - Ping An Good Doctor is engaged in providing medical and health services through mobile platforms and offline resources [1] - The company operates through two segments: the medical services segment, which includes online consultations, referrals, appointment scheduling, hospitalization arrangements, disease diagnosis, and related sales of pharmaceuticals and medical devices [1] - The health services segment offers standardized health service packages that integrate various medical health institution services to meet users' health-related needs, covering categories such as physical examinations, elderly care, dental services, anti-aging, and general health [1]

Core Viewpoint - The internet healthcare sector experienced a slight decline of 0.1% on February 12, with Haixia Innovation leading the drop [1] Market Performance - The Shanghai Composite Index closed at 4134.02, up by 0.05% - The Shenzhen Component Index closed at 14283.0, up by 0.86% [1] Capital Flow - The internet healthcare sector saw a net outflow of 75.07 million yuan from main funds - Retail investors contributed a net inflow of 246 million yuan - Speculative funds experienced a net outflow of 171 million yuan [1]

Group 1 - The Hong Kong innovative drug concept stocks have declined, with companies such as 3SBio, Kelun-Botai Biopharmaceuticals falling over 3%, and CSPC Pharmaceutical Group, China Biologic Products, and Hansoh Pharmaceutical dropping over 2% [1] - The Hong Kong innovative drug-related ETFs have also seen a decline of over 2% [1] Group 2 - Current analysis indicates that the healthcare sector presents multiple investment opportunities, with the CXO industry experiencing sustained improvement due to a recovery in overseas orders and domestic capacity reduction, while still having room for valuation recovery [2] - The medical device sector is benefiting from domestic equipment upgrade policies and overseas market expansion, with continuous catalysts in cutting-edge areas such as brain-computer interfaces and AI imaging [2] - Internet healthcare is seeing improved operational efficiency in the context of deepening medical insurance payment reforms, leading to a clearer profit growth trajectory [2]

Group 1 - The core point of the article highlights the financial performance and stock movement of Langma Information (300288), indicating a decline in both stock price and key financial metrics [1][2]. - As of February 11, 2026, Langma Information's stock closed at 14.75 yuan, down 1.14%, with a turnover rate of 2.52% and a trading volume of 64,700 hands, resulting in a transaction amount of 95.62 million yuan [1]. - The net outflow of main funds on February 11 was 11.70 million yuan, accounting for 12.24% of the total transaction amount, while retail investors saw a net inflow of 10.84 million yuan, representing 11.35% of the total [1]. Group 2 - For the first three quarters of 2025, Langma Information reported a main revenue of 224 million yuan, a year-on-year decrease of 24.75%, and a net profit attributable to shareholders of 13.51 million yuan, down 67.04% [2]. - In the third quarter of 2025, the company recorded a single-quarter main revenue of 72.53 million yuan, a decline of 36.46%, and a net profit of -0.93 million yuan, reflecting a year-on-year decrease of 105.48% [2]. - The company's debt ratio stands at 17.27%, with investment income of 16.99 million yuan and a gross profit margin of 29.25% [2].

Core Viewpoint - The internet healthcare sector experienced a decline of 0.53% on February 11, with significant movements in the stock market and capital flow [1] Market Performance - On February 11, the Shanghai Composite Index closed at 4131.98, reflecting an increase of 0.09% [1] - The Shenzhen Component Index closed at 14160.93, showing a decrease of 0.35% [1] Capital Flow - The internet healthcare sector saw a net outflow of 928 million yuan from major funds on the same day [1] - Retail investors contributed a net inflow of 827 million yuan, while speculative funds saw a net inflow of 101 million yuan [1]